Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q1 2023 Earnings Call Transcript

Operator: Good day, everyone, and welcome to the Syndax First Quarter 2023 Earnings Conference Call. Today's call is being recorded.

Related Keywords

United States ,American ,Anjali Ganguli ,Eva Privitera ,Kalpit Patel ,Brad Canino ,Neil Gallagher ,Sharon Klahre ,Anupam Rama ,Madhu Kumar ,Michael Metzger ,Peter Lawson ,Dara Azar ,Incyte Jakafi ,Keith Goldan ,Sanofi Rezurock ,Yigal Nochomovitz ,Peter Ordentlich ,Kevin Mcmanus ,Justin Zelin ,Joel Beatty ,Syndax Pharmaceuticals Inc ,Lymphoma Society ,American Thoracic Society Conference On ,Barclays ,Nasdaq ,Lymphoma Group ,Goldman Sachs ,Citigroup ,Head Of Investor Relations At Syndax Pharmaceuticals ,Syndax Pharmaceuticals ,Call Transcript May ,Syndax First Quarter ,Investor Relations ,Chief Executive Officer ,Chief Financial ,Chief Scientific Officer ,Chief Business ,Private Securities Litigation Reform Act ,Risk Factors ,Chief People ,Breakthrough Therapy ,Master Clinical Trial ,Australasian Leukaemia ,Clinical Oncology ,Lee Symptom ,American Thoracic Society Conference ,Maybei Ll ,Real Time Oncology Review ,American Thoracic Society Annual Meeting ,European Hematology Association Annual Meeting ,Goldman Sachs Healthcare Conference ,